Here's the latest biotech from a serial entrepreneur whose last company sold for $600M

Here's why former Forge CEO Tim Miller has licensed a gene therapy (again) from Nationwide Children's for "unfinished ...
IFA Magazine

Pension Regulator’s 2026 annual funding statement – further evidence that most schemes are now focusing on endgame planning and potential surplus use

The Pensions Regulator (TPR) has today issued its 2026 Annual Funding Statement. This is the second such statement since the start of the new funding regime ...